NCT03345667View on ClinicalTrials.gov

Assessment of Color Vision in Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

October 1, 2017

Study Completion Date

October 30, 2017

Conditions
Retinopathy, Diabetic
Interventions
DRUG

lucentis

Use of lucentis and other anti-vegf in patients with diabetic retinopathy

Trial Locations (1)

74110120

Instituto de Olhos de Goiania, Goiânia

All Listed Sponsors
lead

Instituto de Olhos de Goiania

OTHER

NCT03345667 - Assessment of Color Vision in Diabetic Patients | Biotech Hunter | Biotech Hunter